The Scientific Acceleration Programme for the PALOP is designed to equip young graduates with the interdisciplinary skills needed to pursue advanced studies (Master’s or PhD) or to enter research institutions or industry in the fields of health and life sciences.

The programme also aims to strengthen scientific networks within the PALOP, foster collaboration with other African countries, and build partnerships with Portugal, opening up new opportunities for research and development.

Ultimately, it seeks to help train a new generation of scientists with a broad, multidisciplinary understanding of health and life sciences.

Running for up to 18 months, the programme comprises 10 months of theoretical training at the University of Cabo Verde (Praia) and 6 months of placement at a scientific or technological institution in Europe (preferably Portugal) or in Africa.

Up to 20 scholarships will be awarded. The programme will run from January 2026 to July 2027.

Eligibility criteria

• A degree in Health or Life Sciences obtained from a higher education institution in the PALOP after 2022, with a minimum average mark of 14.0 (out of 20).
• No Master’s degree.
• Intermediate or advanced level of English.
• Nationality and residence in Angola, Cabo Verde, Guinea-Bissau, Mozambique or São Tomé and Príncipe.
• Aged 30 or under (as of 31 December 2025).

Clarification of any doubts may be carried out until 18 September 2025 by sending an email to [email protected]

How to apply

• Only online applications will be accepted;
• Register on MyGulbenkian;
• Before submitting the application form, check all eligibility criteria. We recommend reading the Call Conditions and Program Structure (available in the Documents section);
• The application can only be submitted once all required fields in the form are completed and all documents required by the Call Conditions have been uploaded;
• Finally, click the “Submit Application” button. To avoid difficulties in submitting your application, do not wait until the last days of the deadline.